학술논문
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
Document Type
Article
Author
Kasner, S.E.; Messé, S.R.; Sharma, M.; Swaminathan, B.; Perera, K.; Lavados, P.; Muir, K.; Veltkamp, R.; Ameriso, S.F.; Endres, M.; Lutsep, H.; Spence, J.D.; Nedeltechev, K.; Santo, G.; Olavarria, V.; Lindgren, A.; Bangdiwala, S.; Shoamanesh, A.; Hart, R.G.; Connolly, S.J.; Berkowitz, S.D.; Mundl, H.
Source
In: The Lancet Neurology . (The Lancet Neurology, 01 December 2018, 17(12):1053-1060)
Subject
Language
English
ISSN
14744465
14744422
14744422